Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques - a review

Analytica Chimica Acta

Volumn 874, Issue , 2015, Pages 11-25

  Znaleziona, Joanna ^a   Ginterová, Pavlína ^a   Petr, Jan ^a   Ondra, Peter ^b   Válka, Ivo ^b   Ševčík, Juraj ^a   Chrastina, Jan ^a   Maier, Vítězslav ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Biological matrices; Herbal blends; Mass spectrometry; New designer drugs; Separation methods; Synthetic cannabinoids

Indexed keywords

CAPILLARY ELECTROPHORESIS; DIRECT INJECTION; DRUG INTERACTIONS; GAS CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; THIN LAYER CHROMATOGRAPHY;

BIOLOGICAL MATRIXES; DESIGNER DRUGS; DIRECT INJECTION MASS SPECTROMETRIES; GAS AND LIQUID CHROMATOGRAPHIES; SAMPLE PREPARATION; SEPARATION AND IDENTIFICATION; SEPARATION METHODS; SYNTHETIC CANNABINOIDS;

LIQUID CHROMATOGRAPHY;

CANNABINOID DERIVATIVE; DRUG METABOLITE; HERBACEOUS AGENT; CANNABINOID; DESIGNER DRUG;

BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; DIRECT ANALYSIS IN REAL TIME MASS SPECTROMETRY; DIRECT INJECTION MASS SPECTROMETRY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG STRUCTURE; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; IMMUNOASSAY; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POWDER; PRIORITY JOURNAL; REVIEW; SALIVA ANALYSIS; SOLID PHASE EXTRACTION; SOLVENT EXTRACTION; THIN LAYER CHROMATOGRAPHY; URINALYSIS; ANIMAL; CHEMICAL ANALYSIS; DEVICES; METABOLISM; PROCEDURES;

ANIMALS; CANNABINOIDS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, THIN LAYER; DESIGNER DRUGS; ELECTROPHORESIS, CAPILLARY; HUMANS; MASS SPECTROMETRY; SOLID PHASE EXTRACTION;

EID: 84928209030     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2014.12.055     Document Type: Review

References (138)

1. New drugs in Europe, 2012 EMCDDA-Europol 2012 Annual Report on the Implementation of Council Decision 2005/387/JHA, EMCDDA, 2012. (accessed 17.07.14). http://file:///C:/Users/znalezij/Downloads/EMCDDA-Europol%202012%20Annual%20Report_final%20(3).pdf.
2. Synthetic cannabinoids in herbal products, Requests the United Nations Office on Drugs and Crime, n.d. (accessed 17.07.14). http://https://www.unodc.org/documents/scientific/Synthetic_Cannabinoids.pdf.
3. Consideration of the major cannabinoid agonists, ACMD, n.d. (accessed 17.07.14). http://forendex.southernforensic.org/uploads/references/Consideration_of_the_major_cannabinoid_agonists.pdf.
4. Auwärter V., Dresen S., Weinmann W., Müller M., Pütz M., Ferreirós N. Spice and other herbal blends: harmless incense or cannabinoid designer drugs?. J. Mass Spectrom. 2009, 44:832-837. 10.1002/jms.1558.
5. Uchiyama N., Kikura-Hanajiri R., Kawahara N., Haishima Y., Goda Y. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. (Tokyo) 2009, 57:439-441. 10.1248/cpb.57.439.
6. World Drug Report, 2014, n.d. http://https://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf.
7. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
8. Thakur G.A., Nikas S.P., Makriyannis A. CB1 cannabinoid receptor ligands. Mini Rev. Med. Chem. 2005, 5:631-640.
9. Huestis M.A., Gorelick D.A., Heishman S.J. Blockade of effects of smoked marijuana by the cb1-selective cannabinoid receptor antagonist sr141716. Arch. Gen. Psychiatry 2001, 58:322-328. 10.1001/archpsyc.58.4.322.
10. Van Gaal L.F., Rissanen A.M., Scheen A.J., Ziegler O., Rössner S., RIO-Europe Study Group Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005, 365:1389-1397. 10.1016/S0140-6736(05)66374-X.
11. Rajasekaran M., Brents L.K., Franks L.N., Moran J.H., Prather P.L. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicol. Appl. Pharmacol. 2013, 269:100-108. 10.1016/j.taap.2013.03.012.
12. Hermanns-Clausen M., Kneisel S., Szabo B., Auwärter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 2013, 108:534-544. 10.1111/j.1360-0443.2012.04078.x.
13. Wells D.L., Ott C.A. The new marijuana. Ann. Pharmacother. 2011, 45:414-417. 10.1345/aph.1P580.
14. Vardakou I., Pistos C., Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol. Lett. 2010, 197:157-162. 10.1016/j.toxlet.2010.06.002.
15. Gómez-Ruiz M., Hernández M., de Miguel R., Ramos J.A. An overview on the biochemistry of the cannabinoid system. Mol. Neurobiol. 2007, 36:3-14. 10.1007/s12035-007-0015-0.
16. Huffman J.W. Cannabimimetic Indoles, Pyrroles, and Indenes: Structure-Activity Relationships and Receptor Interactions 2009, Humana Press, New York.
17. Aung M.M., Griffin G., Huffman J.W., Wu M.-J., Keel C., Yang B., Showalter V.M., Abood M.E., Martin B.R. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Depend. 2000, 60:133-140. 10.1016/S0376-8716(99)00152-0.
18. Huffman J.W., Zengin G., Wu M.-J., Lu J., Hynd G., Bushell K., Thompson A.L.S., Bushell S., Tartal C., Hurst D.P., Reggio P.H., Selley D.E., Cassidy M.P., Wiley J.L., Martin B.R. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl) indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorg. Med. Chem. 2005, 13:89-112. 10.1016/j.bmc.2004.09.050.
19. Lapoint J., James L.P., Moran C.L., Nelson L.S., Hoffman R.S., Moran J.H. Severe toxicity following synthetic cannabinoid ingestion. Clin. Toxicol. 2011, 49:760-764. 10.3109/15563650.2011.609822.
20. Schneir A.B., Cullen J., Ly B.T. Spice girls: synthetic cannabinoid intoxication. J. Emerg. Med. 2011, 40:296-299. 10.1016/j.jemermed.2010.10.014.
21. Seely K.A., Lapoint J., Moran J.H., Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39:234-243. 10.1016/j.pnpbp.2012.04.017.
22. Salim K., Schneider U., Burstein S., Hoy L., Karst M. Pain measurements and side effect profile of the novel cannabinoid ajulemic acid. Neuropharmacology 2005, 48:1164-1171. 10.1016/j.neuropharm.2005.02.010.
23. Zurier R.B., Sun Y.-P., George K.L., Stebulis J.A., Rossetti R.G., Skulas A., Judge E., Serhan C.N. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB J. 2009, 23:1503-1509. 10.1096/fj.08-118323.
24. Ware M.A., Daeninck P., Maida V. A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting. Ther. Clin. Risk Manag. 2008, 4:99-107.
25. Hanasono G.K., Sullivan H.R., Gries C.L., Jordan W.H., Emmerson J.L. A species comparison of the toxicity of nabilone, a new synthetic cannabinoid. Fundam. Appl. Toxicol. Off. J. Soc. Toxicol. 1987, 9:185-197.
26. Wohlfarth A., Gandhi A.S., Pang S., Zhu M., Scheidweiler K.B., Huestis M.A. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Anal. Bioanal. Chem. 2014, 406:1763-1780. 10.1007/s00216-014-7668-0.
27. Hutter M., Moosmann B., Kneisel S., Auwärter V. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J. Mass Spectrom. 2013, 48:885-894. 10.1002/jms.3229.
28. Zhang Q., Ma P., Iszard M., Cole R.B., Wang W., Wang G. In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate, a cannabinoid receptor agonist. Drug Metab. Dispos. 2002, 30:1077-1086. 10.1124/dmd.30.10.1077.
29. Zhang Q., Ma P., Cole R.B., Wang G. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Anal. Bioanal. Chem. 2006, 386:1345-1355. 10.1007/s00216-006-0717-6.
30. Kim U., Jin M.J., Lee J., Han S.B., In M.K., Yoo H.H. Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS. J. Pharm. Biomed. Anal. 2012, 64-65:26-34. 10.1016/j.jpba.2012.02.007.
31. Wintermeyer A., Möller I., Thevis M., Jübner M., Beike J., Rothschild M.A., Bender K. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Anal. Bioanal. Chem. 2010, 398:2141-2153. 10.1007/s00216-010-4171-0.
32. Möller I., Wintermeyer A., Bender K., Jübner M., Thomas A., Krug O., Schänzer W., Thevis M. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test. Anal. 2011, 3:609-620. 10.1002/dta.158.
33. Zhang Q., Ma P., Wang W., Cole R.B., Wang G. Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 2004, 39:672-681. 10.1002/jms.640.
34. Thomas B.F., Martin B.R. In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol, a synthetic bicyclic cannabinoid analog. Drug Metab. Dispos. 1990, 18:1046-1054.
35. Hutter M., Broecker S., Kneisel S., Auwärter V. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in herbal mixtures using LC-MS/MS techniques. J. Mass Spectrom. 2012, 47:54-65. 10.1002/jms.2026.
36. Kavanagh P., Grigoryev A., Melnik A., Savchuk S., Simonov A., Rozhanets V. Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS. J. Chromatogr. B 2013, 934:102-108. 10.1016/j.jchromb.2013.07.005.
37. Brabanter N.D., Esposito S., Tudela E., Lootens L., Meuleman P., Leroux-Roels G., Deventer K., Eenoo P. In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200. Rapid Commun. Mass Spectrom. 2013, 27:2115-2126. 10.1002/rcm.6673.
38. Brabanter N.D., Esposito S., Geldof L., Lootens L., Meuleman P., Leroux-Roels G., Deventer K., Eenoo P. In vitro and in vivo metabolisms of 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122). Forensic Toxicol. 2013, 31:212-222. 10.1007/s11419-013-0179-4.
39. Wohlfarth A., Pang S., Zhu M., Gandhi A.S., Scheidweiler K.B., Liu H.-F., Huestis M.A. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clin. Chem. 2013, 59:1638-1648. 10.1373/clinchem.2013.209965.
40. Gambaro V., Arnoldi S., Bellucci S., Casagni E., Dell'Acqua L., Fumagalli L., Pallavicini M., Roda G., Rusconi C., Valoti E. Characterization of in vitro metabolites of JWH-018, JWH-073 and their 4-methyl derivatives, markers of the abuse of these synthetic cannabinoids. J. Chromatogr. B 2014, 957:68-76. 10.1016/j.jchromb.2014.03.001.
41. Sobolevsky T., Prasolov I., Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 2010, 200:141-147. 10.1016/j.forsciint.2010.04.003.
42. Chimalakonda K.C., Moran C.L., Kennedy P.D., Endres G.W., Uzieblo A., Dobrowolski P.J., Fifer E.K., Lapoint J., Nelson L.S., Hoffman R.S., James L.P., Radominska-Pandya A., Moran J.H. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal. Chem. 2011, 83:6381-6388. 10.1021/ac201377m.
43. Grigoryev A., Melnik A., Savchuk S., Simonov A., Rozhanets V. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. J. Chromatogr. B 2011, 879:2519-2526. 10.1016/j.jchromb.2011.07.004.
44. Sobolevsky T., Prasolov I., Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug. Test. Anal. 2012, 4:745-753. 10.1002/dta.1418.
45. Chimalakonda K.C., Bratton S.M., Le V.-H., Yiew K.H., Dineva A., Moran C.L., James L.P., Moran J.H., Radominska-Pandya A. Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases. Drug Metab. Dispos. 2011, 39:1967-1976. 10.1124/dmd.111.040709.
46. Beuck S., Möller I., Thomas A., Klose A., Schlörer N., Schänzer W., Thevis M. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Anal. Bioanal. Chem. 2011, 401:493-505. 10.1007/s00216-011-4931-5.
47. ElSohly M.A., Gul W., ElSohly K.M., Murphy T.P., Madgula V.L.M., Khan S.I. Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. J. Anal. Toxicol. 2011, 35:487-495. 10.1093/anatox/35.7.487.
48. Moran C.L., Le V.-H., Chimalakonda K.C., Smedley A.L., Lackey F.D., Owen S.N., Kennedy P.D., Endres G.W., Ciske F.L., Kramer J.B., Kornilov A.M., Bratton L.D., Dobrowolski P.J., Wessinger W.D., Fantegrossi W.E., Prather P.L., James L.P., Radominska-Pandya A., Moran H.J. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal. Chem. 2011, 83:4228-4236. 10.1021/ac2005636.
49. Sobolevsky T.G., Prasolov I.S., Rodchenkov G.M. Application of mass spectrometry to the structural identification of the metabolites of the synthetic cannabinoid JWH-018 and the determination of them in human urine. J. Anal. Chem. 2011, 66:1314-1323. 10.1134/S1061934811130090.
50. Grigoryev A., Savchuk S., Melnik A., Moskaleva N., Dzhurko J., Ershov M., Nosyrev A., Vedenin A., Izotov B., Zabirova I., Rozhanets V. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2011, 879:1126-1136. 10.1016/j.jchromb.2011.03.034.
51. Kraemer T., Rust K.Y., Meyer M., Wissenbach D., Bregel D., Hopf M., Maurer H., Wilske J. Studies on the metabolism of JWH-018 and of a homologue of CP 47,497, pharmacologically active ingredients of different misused incense Spice using GC-MS and LCMSn techniques. Ann. Toxicol. Anal. 2001, 21(S1):21.
52. Jang M., Yang W., Shin I., Choi H., Chang H., Kim E. Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse. Int. J. Leg. Med. 2014, 128:285-294. 10.1007/s00414-013-0884-x.
53. Kacinko S.L., Xu A., Homan J.W., McMullin M.M., Warrington D.M., Logan B.K. Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. J. Anal. Toxicol. 2011, 35:386-393. 10.1093/anatox/35.7.386.
54. Dresen S., Kneisel S., Weinmann W., Zimmermann R., Auwärter V. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J. Mass Spectrom. 2011, 46:163-171. 10.1002/jms.1877.
55. Batista C., Berisha M., Karst M., Salim K., Schneider U., Brenneisen R. Determination of ajulemic acid and its glucuronide in human plasma by gas chromatography-mass spectrometry. J. Chromatogr. B 2005, 820:77-82. 10.1016/j.jchromb.2005.03.013.
56. Hutter M., Kneisel S., Auwärter V., Neukamm M.A. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2012, 903:95-101. 10.1016/j.jchromb.2012.07.002.
57. Salomone A., Gerace E., D'Urso F., Di Corcia D., Vincenti M. Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J. Mass Spectrom. 2012, 47:604-610. 10.1002/jms.2988.
58. Cirimele V., Klinger N., Etter M., Duez M., Humbert L., Gaulier J.-M., Allorge D. O21: testing for 18 synthetic cannabinoids in hair using HPLC-MS/MS: method development and validation, its application to authentic samples and preliminary results. Toxicol. Anal. Clin. 2014, 26:S13. 10.1016/S2352-0078(14)70029-0.
59. Coulter C., Garnier M., Moore C. Synthetic cannabinoids in oral fluid. J. Anal. Toxicol. 2011, 35:424-430. 10.1093/anatox/35.7.424.
60. Ammann J., McLaren J.M., Gerostamoulos D., Beyer J. Detection and quantification of new designer drugs in human blood: part 1 - synthetic cannabinoids. J. Anal. Toxicol. 2012, 36:372-380. 10.1093/jat/bks048.
61. Kneisel S., Bisel P., Brecht V., Broecker S., Müller M., Auwärter V. Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures. Forensic Toxicol. 2012, 30:126-134. 10.1007/s11419-012-0137-6.
62. Ernst L., Krüger K., Lindigkeit R., Schiebel H.-M., Beuerle T. Synthetic cannabinoids in spice-like herbal blends: first appearance of JWH-307 and recurrence of JWH-018 on the German market. Forensic Sci. Int. 2012, 222:216-222. 10.1016/j.forsciint.2012.05.027.
63. Simolka K., Lindigkeit R., Schiebel H.-M., Papke U., Ernst L., Beuerle T. Analysis of synthetic cannabinoids in spice-like herbal highs: snapshot of the German market in summer 2011. Anal. Bioanal. Chem. 2012, 404:157-171. 10.1007/s00216-012-6122-4.
64. Musah R.A., Domin M.A., Walling M.A., Shepard J.R.E. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26:1109-1114. 10.1002/rcm.6205.
65. Kneisel S., Westphal F., Bisel P., Brecht V., Broecker S., Auwärter V. Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in herbal incense. J. Mass Spectrom. 2012, 47:195-200. 10.1002/jms.2059.
66. Gottardo R., Chiarini A., Dal Prà I., Seri C., Rimondo C., Serpelloni G., Armato U., Tagliari F. Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS. J. Mass Spectrom. 2012, 47:141-146. 10.1002/jms.2036.
67. Penn H.J., Langman L.J., Unold D., Shields J., Nichols J.H. Detection of synthetic cannabinoids in herbal incense products. Clin. Biochem. 2011, 44:1163-1165. 10.1016/j.clinbiochem.2011.06.078.
68. Hudson S., Ramsey J. The emergence and analysis of synthetic cannabinoids. Drug Test. Anal. 2011, 3:466-478. 10.1002/dta.268.
69. Hudson S., Ramsey J., King L., Timbers S., Maynard S., Dargan P.I., Wood D.M. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in herbal high products. J. Anal. Toxicol. 2010, 34:252-260. 10.1093/jat/34.5.252.
70. Uchiyama N., Kikura-Hanajiri R., Ogata J., Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci. Int. 2010, 198:31-38. 10.1016/j.forsciint.2010.01.004.
71. Koskela H., Hakala U., Loiske L., Vanninen P., Szilvay I. Separation and structural characterization of a synthetic cannabinoid found in a herbal product using off-line LC-DAD-NMR. Anal. Methods 2011, 3:2307. 10.1039/c1ay05287j.
72. Zuba D., Byrska B., Maciow M. Comparison of herbal highs composition. Anal. Bioanal. Chem. 2011, 400:119-126. 10.1007/s00216-011-4743-7.
73. Dresen S., Ferreirós N., Pütz M., Westphal F., Zimmermann R., Auwärter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J. Mass Spectrom. 2010, 45:1186-1194. 10.1002/jms.1811.
74. Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y. Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicol. 2012, 30:114-125. 10.1007/s11419-012-0136-7.
75. Nakajima J., Takahashi M., Seto T., Yoshida M., Kanai C., Suzuki J., Hamano T. Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated herbal products circulated in the Tokyo area. Forensic Toxicol. 2012, 30:33-44. 10.1007/s11419-011-0130-5.
76. Nekhoroshev S.V., Nekhoroshev V.P., Remizova M.N., Nekhorosheva A.V. Determination of the chemical composition of Spice aromatic smoking blends by chromatography-mass spectrometry. J. Anal. Chem. 2011, 66:1196-1200. 10.1134/S1061934811090115.
77. 2 receptors. Chem. Pharm. Bull. (Tokyo) 2011, 59:1203-1205. 10.1248/cpb.59.1203.
78. Logan B.K., Reinhold L.E., Xu A., Diamond F.X. Identification of synthetic cannabinoids in herbal incense blends in the United States. J. Forensic Sci. 2012, 57:1168-1180. 10.1111/j. 1556-4029.2012.02207.x.
79. T. Macherone, J. Gluodenis, Confirmation and quantification of synthetic cannabinoids in herbal incense blends by triple quadrupole GC/MS, Agilent Technologies, 2012, n.d.
80. Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y. Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 2011, 29:25-37. 10.1007/s11419-010-0100-3.
81. Lesiak A.D., Musah R.A., Domin M.A., Shepard J.R.E. DART-MS as a preliminary screening method for herbal incense: chemical analysis of synthetic cannabinoids. J. Forensic Sci. 2014, 59:337-343. 10.1111/1556-4029.12354.
82. Merola G., Aturki Z., D'Orazio G., Gottardo R., Macchia T., Tagliaro F., Fanali S. Analysis of synthetic cannabinoids in herbal blends by means of nano-liquid chromatography. J. Pharm. Biomed. Anal. 2012, 71:45-53. 10.1016/j.jpba.2012.08.008.
83. Gottardo R., Bertaso A., Pascali J., Sorio D., Musile G., Trapani E., Seri C., Serpelloni G., Tagliaroa F. Micellar electrokinetic chromatography: a new simple tool for the analysis of synthetic cannabinoids in herbal blends and for the rapid estimation of their log P values. J. Chromatogr. A 2012, 1267:198-205. 10.1016/j.chroma.2012.08.085.
84. Nakajima J., Takahashi M., Seto T., Kanai C., Suzuki J., Yoshida M., Hamano T. Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the internet. Forensic Toxicol. 2011, 29:95-110. 10.1007/s11419-011-0108-3.
85. Edmunds R., Locos O., Brown D., Reynolds D. Identification of the synthetic cannabinoid (1-(cyclohexylmethyl)-1H-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone on plant material. Microgram J. 2013, 10:1-7.
86. Choi H., Heo S., Choe S., Yang W., Park Y., Kim E., Chung H., Lee J. Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS. Anal. Bioanal. Chem. 2013, 405:3937-3944. 10.1007/s00216-012-6560-z.
87. Jankovics P., Váradi A., Tölgyesi L., Lohner S., Németh-Palotás J., Balla J. Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary. Forensic Sci. Int. 2012, 214:27-32. 10.1016/j.forsciint.2011.07.011.
88. Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y. Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol. 2011, 29:25-37. 10.1007/s11419-010-0100-3.
89. de Jager A.D., Warner J.V., Henman M., Ferguson W., Hall A. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine - an Australian perspective. J. Chromatogr. B 2012, 897:22-31. 10.1016/j.jchromb.2012.04.002.
90. Dowling G., Regan L. A method for CP 47, 497 a synthetic non-traditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry. J. Chromatogr. B 2011, 879:253-259. 10.1016/j.jchromb.2010.12.008.
91. Kavanagh P., Grigoryev A., Melnik A., Simonov A. The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry. J. Anal. Toxicol. 2012, 36:303-311. 10.1093/jat/bks032.
92. A. Rigdon, P. Kennedy, T. Kahler, LC/MS/MS Analysis of Metabolites of Synthetic Cannabinoids JWH-018 and JWH-073 in Urine (n.d.), . http://www.restek.com/pdfs/CFAN1383.pdf.
93. Arntson A., Ofsa B., Lancaster D., Simon J.R., McMullin M., Logan B. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens. J. Anal. Toxicol. 2013, 37:284-290. 10.1093/jat/bkt024.
94. Adamowicz P., Zuba D., Sekuła K. Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine. Forensic Sci. Int. 2013, 233:320-327. 10.1016/j.forsciint.2013.10.005.
95. Elian A.A., Hackett J. Analysis of AM-2201 and metabolites in a drugs and driving case. Drug Test. Anal. 2014, 6:389-395. 10.1002/dta.1535.
96. Kneisel S., Auwärter V. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 2012, 47:825-835. 10.1002/jms.3020.
97. Teske J., Weller J.-P., Fieguth A., Rothämel T., Schulz Y., Tröger H.D. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2010, 878:2659-2663. 10.1016/j.jchromb.2010.03.016.
98. Rodrigues W.C., Catbagan P., Rana S., Wang G., Moore C. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS. J. Anal. Toxicol. 2013, 37:526-533. 10.1093/jat/bkt067.
99. de Castro A., Piñeiro B., Lendoiro E., Cruz A., López-Rivadulla M. Quantification of selected synthetic cannabinoids and δ9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2013, 1295:99-106. 10.1016/j.chroma.2013.04.035.
100. Øiestad E.L., Johansen U., Christophersen A.S., Karinen R. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS. Bioanalysis 2013, 5:2257-2268. 10.4155/bio.13.182.
101. Amaratunga P., Thomas C., Lemberg B.L., Lemberg D. Quantitative measurement of XLR11 and UR-144 in oral fluid by LC-MS-MS. J. Anal. Toxicol. 2014, 38:315-321. 10.1093/jat/bku040.
102. Poklis J.L., Amira D., Wise L.E., Wiebelhaus J.M., Haggerty B.J., Lichtman A.H., Poklis A. Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to buzz smoke by HPLC/MS/MS. Biomed. Chromatogr. 2012, 26:1393-1398. 10.1002/bmc.2710.
103. Reid M.J., Derry L., Thomas K.V. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances. Drug Test. Anal. 2014, 6:72-79. 10.1002/dta.1461.
104. Ginsburg B.C., McMahon L.R., Sanchez J.J., Javors M.A. Purity of synthetic cannabinoids sold online for recreational use. J. Anal. Toxicol. 2012, 36:66-68. 10.1093/jat/bkr018.
105. Akamatsu S., Mitsuhashi T.S. MEKC-MS/MS method using a volatile surfactant for the simultaneous determination of 12 synthetic cannabinoids. J. Sep. Sci. 2014, 37:304-307. 10.1002/jssc.201301132.
106. Bononi M., Belgi P., Tateo F. Analytical data for identification of the cannabimimetic phenylacetylindole JWH-203. J. Anal. Toxicol. 2011, 35:360-363. 10.1093/anatox/35.6.360.
107. Langer N., Lindigkeit R., Schiebel H.-M., Ernst L., Beuerle T. Identification and quantification of synthetic cannabinoids in spice-like herbal mixtures: a snapshot of the German situation in the autumn of 2012. Drug Test. Anal. 2014, 6:59-71. 10.1002/dta.1499.
108. Moeller K.E., Lee K.C., Kissack J.C. Urine drug screening: practical guide for clinicians. Mayo Clin. Proc. 2008, 83:66-76. 10.4065/83.1.66.
109. Kneisel S., Auwärter V., Kempf J. Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry. Drug Test. Anal. 2013, 5:657-669. 10.1002/dta.1429.
110. Grabenauer M., Krol W.L., Wiley J.L., Thomas B.F. Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: Implications for non-targeted screening of designer drugs. Anal. Chem. 2012, 84:5574-5581. 10.1021/ac300509h.
111. Moosmann B., Kneisel S., Girreser U., Brecht V., Westphal F., Auwärter V. Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system. Forensic Sci. Int. 2012, 220:e17-e22. 10.1016/j.forsciint.2011.12.010.
112. Jin M.J., Lee J., In M.K., Yoo H.H. Characterization of in vitro metabolites of CP 47,497, a synthetic cannabinoid, in human liver microsomes by LC-MS/MS. J. Forensic Sci. 2013, 58:195-199. 10.1111/j.1556-4029.2012.02261.x.
113. Hernández F., Bijlsma L., Sancho J.V., Díaz R., Ibáñez M. Rapid wide-scope screening of drugs of abuse, prescription drugs with potential for abuse and their metabolites in influent and effluent urban wastewater by ultrahigh pressure liquid chromatography-quadrupole-time-of-flight-mass spectrometry. Anal. Chim. Acta. 2011, 684:96-106. 10.1016/j.aca.2010.10.043.
114. Pike E., Rummel M., Trass M., Countryman S. Toxicology labs rely on LC/MS/MS to provide sensitive analysis of synthetic cannabinoids. Am. Lab. 2012, 44:9-12.
115. Barnes A.J., Young S., Spinelli E., Martin T.M., Klette K.L., Huestis M.A. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine. Forensic Sci. Int. 2014, 241:27-34. 10.1016/j.forsciint.2014.04.020.
116. Komsta L., Waksmundzka-Hajnos M., Sherma J. Thin Layer Chromatography in Drug Analysis 2013, CRC Press.
117. Danielson N.D., Gallagher P.A., Bao J.J. Chemical reagents and derivatization procedures in drug analysis. Encyclopedia of Analytical Chemistry 2000, 7042-7076. John Wiley & Sons Ltd., Chichester. R.A. Meyers (Ed.).
118. Tsujikawa K., Yamamuro T., Kuwayama K., Kanamori T., Iwata Y.T., Inoue H. Thermal degradation of a new synthetic cannabinoid QUPIC during analysis by gas chromatography-mass spectrometry. Forensic Toxicol. 2013, 1-7. 10.1007/s11419-013-0221-6.
119. Wu A.H., Gerona R., Armenian P., French D., Petrie M., Lynch K.L. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin. Toxicol. (Phila., PA) 2012, 50:733-742. 10.3109/15563650.2012.713108.
120. Wang S.M., Ling Y.C., Giang Y.S. Forensic applications of supercritical fluid extraction and chromatography. Forensic Sci. J. 2003, 2:5-18.
121. Webster G.K. Supercritical Fluid Chromatography: Advances and Applications in Pharmaceutical Analysis 2014, Pan Stanford Publishing Pte. Ltd., Danvers. http://www.panstanford.com/pdf/9789814463010fm.pdf.
122. Shevyrin V., Melkozerov V., Nevero A., Eltsov O., Shafran Y. Analytical characterization of some synthetic cannabinoids, derivatives of indole-3-carboxylic acid. Forensic Sci. Int. 2013, 232:1-10. 10.1016/j.forsciint.2013.06.011.
123. Binder M., Franke I., Schmidt B., Dietrich W. 13C-NMR spectra of natural and semi-synthetic cannabinoids. Helv. Chim. Acta 1982, 65:807-811. 10.1002/hlca.19820650318.
124. Franke I., Schmidt B., Dietrich W., Binder M. 13C-NMR spectra of cannbinoids. Part 2. Side-chain substituted tetrahydrocannabinols and synthetic intermediates. Helv. Chim. Acta 1984, 67:1233-1237. 10.1002/hlca.19840670509.
125. Mavromoustakos T., Theodoropoulou E., Zervou M., Kourouli T., Papahatjis D. Structure elucidation and conformational properties of synthetic cannabinoids (-)-2-(6a,7,10,10a-tetrahydro-6,6,9-trimethyl-1-hydroxy-6H-dibenzo[b,d]pyranyl)-2-hexyl-1,3-dithiolane and its methylated analog. J. Pharm. Biomed. Anal. 1999, 18:947-956. 10.1016/S0731-7085(98)00100-9.
126. Musah R.A., Domin M.A., Cody R.B., Lesiak A.D., Dane A.J., Shepard J.R.E. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids. Rapid Commun. Mass Spectrom. 2012, 26:2335-2342. 10.1002/rcm.6354.
127. Cody R.B., Laramée J.A., Durst H.D. Direct analysis in real time (DARTtm) mass spectrometry. JEOL News 2005, 40:8-12.
128. Thomas B.F., Pollard G.T., Grabenauer M. Analytical surveillance of emerging drugs of abuse and drug formulations. Life Sci. 2013, 92:512-519. 10.1016/j.lfs.2012.10.031.
129. Brents L.K., Gallus-Zawada A., Radominska-Pandya A., Vasiljevik T., Prisinzano T.E., Fantegrossi W.E., Moran J.H., Prather P.L. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochem. Pharmacol. 2012, 83:952-961. 10.1016/j.bcp.2012.01.004.
130. Guale F., Shahreza S., Walterscheid J.P., Chen H.-H., Arndt C., Kelly A.T., Mozavani A. Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens. J. Anal. Toxicol. 2013, 37(1):17-24. 10.1093/jat/bks084.
131. Ibáñez M., Bijlsma L., van Nuijs A.L.N., Sancho J.V., Haro G., Covaci A., Hernández F. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends. J. Mass Spectrom. 2013, 48:685-694. 10.1002/jms.3217.
132. Sundström M., Pelander A., Angerer V., Hutter M., Kneisel S., Ojanperä I. A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine. Anal. Bioanal. Chem. 2013, 405:8463-8474. 10.1007/s00216-013-7272-8.
133. E. Pike, M. Rummel, M. Trass, J. Layne and S. Countryman, Fast and effective LC/MS/MS analysis of synthetic cannabinoids (technical article), . http://www.americanlaboratory.com/913-Technical-Articles/38056-Fast-and-Effective-LC-MS-MS-Analysis-of-Synthetic-Cannabinoids/.
134. B.K. Logan, S.L. Kacinko, M.M. McMullin, A. Xu, R.A. Middleberg, Technical Bulletin: Identification of primary JWH-018 and JWH-073 metabolites in human urine, 2011.
135. Patton A.L., Seely K.A., Chimalakonda K.C., Tran J.P., Trass M., Miranda A., Fantegrossi W.E., Kennedy P.D., Dobrowolski P., Radominska-Pandya A., McCain K.R., James L.P., Endres G.W., Moran J.H. Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. Anal. Chem. 2013, 85:9390-9399. 10.1021/ac4024704.
136. Dziadosz M., Weller J.-P., Klintschar M., Teske J. Scheduled multiple reaction monitoring algorithm as a way to analyse new designer drugs combined with synthetic cannabinoids in human serum with liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2013, 929:84-89. 10.1016/j.jchromb.2013.04.017.
137. Kim J., In S., Park Y., Park M., Kim E., Lee S. Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Anal. Bioanal. Chem. 2013, 405:9769-9778. 10.1007/s00216-013-7423-y.
138. Kneisel S., Speck M., Moosmann B., Corneillie T., Butlin N., Auwärter V. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Anal. Bioanal. Chem. 2013, 405:4691-4706. 10.1007/s00216-013-6887-0.